IBB
ETF / Mutual Fund
NASDAQ
iShares Biotechnology ETF
Health Care
$125.32
-$6.31 (-4.78%)
Price Chart
Overview
About IBB
An ETF that tracks the performance of the biotechnology sector in the United States.
AUM
$10.0B
Volume
278.9M
Avg. Volume
262.0M
Expense Ratio
0.45%
Fund Information
Exchange
NASDAQ
Sector
Health Care
Industry
Biotechnology
Latest News for IBB
Trump Says Pharmaceutical Tariffs Coming in Near Future
April 14, 2025
Trump's pharmaceutical tariffs could raise costs for patients, worsen drug shortages
April 11, 2025
Fast Money: WTI, IBB, UBER, CAT
June 13, 2025
Biotech walks a 'tightrope' amid unclear funding, regulations
January 31, 2025
Is iShares Biotechnology ETF (IBB) a Strong ETF Right Now?
June 18, 2025
Risk & Correlation Analysis
Market Correlation
0.67
Low Correlation
Volatility
Low (0.18)
Relative to market
Macro Factor Sensitivities
Interest Rates
Low Sensitivity
Inflation
Medium Sensitivity
GDP Growth
Low Sensitivity
Liquidity
Low Sensitivity
Commodity Prices
Low Sensitivity
Credit Quality
Medium Sensitivity
Portfolio Impact
Forecasts & Predictions
1-Month Target
$XXX.XX
+X.X% Potential
3-Month Target
$XXX.XX
+X.X% Potential
12-Month Target
$XXX.XX
+X.X% Potential
Technical Analysis
Based on technical indicators and chart patterns, IBB shows...
AI Sentiment Analysis
Market sentiment analysis indicates...
Key Statistics
AUM$10.0B
Volume278.9M
Expense Ratio0.45%
Important Dates
Next Dividend
Next Earnings
Related Securities
Pricing info last updated June 17, 2025 (after market close)Other info last updated April 2, 2025